location: Current position: Home >> Scientific Research >> Paper Publications

Simultaneous inhibition of FLT3 and HDAC by novel 6-ethylpyrazine-2-Carboxamide derivatives provides therapeutic advantages in acute myelocytic leukemia

Hits:

Affiliation of Author(s):药学院

Journal:EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

First Author:Chang, Yingjie

Document Code:1843556249584635906

Volume:279

Number of Words:9

Translation or Not:no

Date of Publication:2024-12-05

Next One:Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity